Latest Interviews Life Sciences Podcast Episodes
10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles
Editors in Conversation - April 19, 2024 22:11 - 37 minutes ★★★★ - 10 ratingsRhodococcus infections are uncommon, however they can cause serious disease in certain patients. There are a number of challenges though when dealing with Rhodococcus infections, including the fact that much of what we know around their susceptibility profiles and the clinical management of infe...
Why Phage Therapy May Fail
Editors in Conversation - April 05, 2024 21:55 - 37 minutes ★★★★ - 10 ratingsPhage therapy has gained a lot of traction but the challenges created by this approach have not been properly assessed at a big scale. We often read about therapy successes on isolated cases but, rarely, we read or hear about failures. AAC recently published a case series of patients who failed ...
Is Lophomonas a Pathogen?
Editors in Conversation - February 23, 2024 21:48 - 34 minutes ★★★★ - 10 ratingsThe protozoan Lophomonas has been reported to be a pathogen of humans in a large number of case reports and case series. Most of these case reports describe infections of the respiratory tract. Editors in Conversation is joined by two experts to discuss this possible parasite. Some of the que...
Treatment of Multidrug-resistant Tuberculosis
Editors in Conversation - February 09, 2024 22:55 - 40 minutes ★★★★ - 10 ratingsTuberculosis is one of the most deadly infectious diseases that still causes significant burden of disease, particularly in the developing world. The emergence of resistance to first line agents severely limits the therapeutic options and threaten the ability to control dissemination of this di...
New generation B-lactam/B-lactamase inhibitors: Taniborbactam
Editors in Conversation - January 13, 2024 03:46 - 47 minutes ★★★★ - 10 ratingsA new generation of B-lactamase inhibitors is likely to reach the market in the upcoming year. These broad-spectrum inhibitors exhibit activity against the most feared class B metallo-B-lactamases maintaining the inhibition of other enzymes. Recently AAC has published three papers that describe ...
Favorite Clinical Microbiology Papers of 2023 (JCM ed.)
Editors in Conversation - December 23, 2023 00:32 - 1 hour ★★★★ - 10 ratingsWe managed to make it through 2023 without a major epidemic or pandemic, and as we get into the holiday spirit and look forward to the new year, some of us took a look back and picked out one of our favorite JCM paper published in 2023, which I will tell you, was no easy task as there were many ...
Antimicrobial Resistance in Neisseria Gonorrhoeae (JCM ed.)
Editors in Conversation - December 05, 2023 08:18 - 28 minutes ★★★★ - 10 ratingsGonorrhea remains one of the more common sexually transmitted infections. In North America, the number of reported cases has generally risen for over ten years, with interruptions in the early days of the COVID-19 pandemic, followed by returns to rising rates of infection. Under the selective pr...
New Antifungals (AAC ed.)
Editors in Conversation - November 10, 2023 22:15 - 45 minutes ★★★★ - 10 ratingsIn the last few years we have witnessed the rise of very resistant fungal species some of them likely influenced by environmental conditions and climate change. Fortunately, there has been a bit of an explosion in the development of new antifungals and the pipeline has been strengthened in the l...
A Novel Coccidioides Antibody LFA (JCM ed.)
Editors in Conversation - October 20, 2023 23:51 - 44 minutes ★★★★ - 10 ratingsDespite the many advances in diagnostic testing for infectious diseases, detection of Coccidoides infections continues to rely on serologic assessment for anti-fungal antibodies, and what is perhaps more astonishing is that the serologic methods we use today, such as complement fixation and immu...
Climate Change and Antimicrobial Resistance (AAC ed.)
Editors in Conversation - October 07, 2023 07:05 - 29 minutes ★★★★ - 10 ratingsClimate change is possibly the major threat that planet earth is experiencing in this century with potential catastrophic consequences. As the planet warms, the change in weather patterns is affecting the microbial ecology in such a manner that humans are facing new health threats including emer...
Emerging Antifungal-Resistant Dermatophytes (JCM ed.)
Editors in Conversation - September 22, 2023 23:35 - 29 minutes ★★★★ - 10 ratingsFungi that are resistant to antifungal drugs have been very much in the news and even the subject of the hugely popular television program, The Last of Us. We talk with two experts in mycology and fungal susceptibility testing about the recent descriptions of terbinafine-resistant dermatophytes ...
Artificial Intelligence and Infectious Diseases
Editors in Conversation - September 08, 2023 23:12 - 38 minutes ★★★★ - 10 ratingsArtificial intelligence (AI) has the potential to change the way we practice medicine and public health. The tools and AI approaches can substantially impact a broad range of fields from the manner we approach patient care to strategies to discover new antimicrobials, track pandemics and deploy ...
Artificial Intelligence and Infectious Diseases (AAC ed.)
Editors in Conversation - September 08, 2023 23:12 - 38 minutes ★★★★ - 10 ratingsArtificial intelligence (AI) has the potential to change the way we practice medicine and public health. The tools and AI approaches can substantially impact a broad range of fields from the manner we approach patient care to strategies to discover new antimicrobials, track pandemics and deploy ...
Viral Outbreaks in the Headlines (JCM ed.)
Editors in Conversation - August 18, 2023 23:46 - 26 minutes ★★★★ - 10 ratingsDr. Elli Theel and Dr. Alex McAdam discuss recent viral outbreaks with expert virologists. Recorded before a live audience at ASM Microbe 2023. Topics: What are the recent epidemiologic and diagnostic findings with Mpox? What are the reservoirs for influenza A H5N1 and how is it transmitte...
AAC Launches a New Section Focused On Antimicrobial Stewardship
Editors in Conversation - August 04, 2023 20:22 - 37 minutes ★★★★ - 10 ratingsIn response to the global burden of antimicrobial resistance (AMR) and the critical role antimicrobial stewardship plays in optimizing antibiotic use and reducing the subsequent emergence of AMR, Antimicrobial Agents and Chemotherapy is excited to add a new section to the journal focused on anti...
AAC Launches a New Section Focused On Antimicrobial Stewardship (AAC ed.)
Editors in Conversation - August 04, 2023 20:22 - 37 minutes ★★★★ - 10 ratingsIn response to the global burden of antimicrobial resistance (AMR) and the critical role antimicrobial stewardship plays in optimizing antibiotic use and reducing the subsequent emergence of AMR, Antimicrobial Agents and Chemotherapy is excited to add a new section to the journal focused on anti...
Susceptibility Testing for Aztreonam with Ceftazidime-Avibactam
Editors in Conversation - July 13, 2023 20:30 - 38 minutes ★★★★ - 10 ratingsThe combination of aztreonam with ceftazidime-avibactam is increasingly used for treatment of antimicrobial-resistant Gram-negative bacilli. Clinical laboratories are asked to perform susceptibility testing using this combination, but many laboratory directors have been unsure how to approach th...
Susceptibility Testing for Aztreonam with Ceftazidime-Avibactam (JCM ed.)
Editors in Conversation - July 13, 2023 20:30 - 38 minutes ★★★★ - 10 ratingsThe combination of aztreonam with ceftazidime-avibactam is increasingly used for treatment of antimicrobial-resistant Gram-negative bacilli. Clinical laboratories are asked to perform susceptibility testing using this combination, but many laboratory directors have been unsure how to approach th...
Hispanic Leadership in Vaccine Sciences With Dr. Maria Elena Bottazzi (AAC ed.)
Editors in Conversation - June 30, 2023 20:49 - 28 minutes ★★★★ - 10 ratingsRecorded at ASM Microbe 2023, Cesar has a conversation with Dr. Maria Elena Bottazzi about the role of minority women in science and discovery, the journey of Hispanic women in science and the current challenges posed by society to deliver science and global health equity. Guest: Dr. Maria El...
Embracing Innovation and Collaboration in the Pharma Industry with Dr. Nedim Pipic
IDEA Collider - June 15, 2023 07:36 - 39 minutes ★★★★★ - 2 ratingsWelcome to another episode of Idea Collider with your host, Mike Rea. In this engaging conversation, we delve into the world of pharmaceutical innovation and collaboration. Our guest, Dr. Nedim Pipic, a pharmaceutical expert specializing in mental and retinal health, shares his journey and pas...
Updates on Testing for Vaginitis/Vaginosis (JCM ed.)
Editors in Conversation - June 03, 2023 00:13 - 40 minutes ★★★★ - 10 ratingsAs many of you are likely aware, May is recognized as Women’s Health Care Month by the National Cervical Cancer Coalition, and this year, the CDC has identified the week of May 14th as National Women’s Health Week. So, what better way to recognize these national events on the podcast than to tal...
Management of Difficult to Treat HSV and CMV Infections (AAC ed.)
Editors in Conversation - May 01, 2023 19:15 - 45 minutes ★★★★ - 10 ratingsAs the number of immunocompromised patients rise in our hospitals, the presentation of severe infections caused by HSV and CMV are rising. Most importantly, lack of response and documented resistance are becoming more frequently observed. Topics discussed: The clinical problems caused by resi...
Susceptibility Testing for Piperacillin-Tazobactam (JCM ed.)
Editors in Conversation - April 08, 2023 07:34 - 49 minutes ★★★★ - 10 ratingsSusceptibility testing for piperacillin-tazobactam has undergone rapid evolution, largely driven by some surprising results from the MERINO trial, which compared the efficacy of piperacillin-tazobactam and meropenem for treatment of patients with ceftriaxone-resistant E. coli or Klebsiella pneum...
Antimicrobial Resistance in Neisseria gonorrhoeae (AAC ed.)
Editors in Conversation - March 24, 2023 09:00 - 44 minutes ★★★★ - 10 ratingsThe Center of Diseases Control and Prevention (CDC) has categorized emergent resistance in Neisseria gonorrhoeae as an “urgent” public health problem. We discuss the emerging problem of gonorrhea and implications for public health with experts in the field Topics discussed: The clinical impli...
Vivek Polshettiwar – Catalyst for change
Modern Chemistry Podcast - March 23, 2023 03:30 - 28 minutesProfessor Polshettiwar is based at the Prestigious Tata Institute of Fundamental Research (TIFR) (https://www.tifr.res.in). Prof Polshettiwar was educated at a number of institutions across India, before he moved to France, the United States, and Saudi Arabia. In 2013 he joined the TIFR. Prof V...
Avoiding HIV False Positives (JCM ed.)
Editors in Conversation - February 24, 2023 12:00 - 29 minutes ★★★★ - 10 ratingsWe can probably all agree that any false positive test result is bad, but I think it’s safe to say that some false positives, like a false positive HIV test for example, is much more anxiety provoking than others. And when it comes to HIV, there have been a number of key advances in the field ov...
Discussing β-lactamase/β-lactamase inhibitors (AAC ed.)
Editors in Conversation - February 10, 2023 11:00 - 51 minutes ★★★★ - 10 ratingsNovel β-lactamase/β-lactamase inhibitors have become critical drugs to combat the most resistant Gram-negative infections. A series of new compounds with even more broad and potent activity are in the horizon to add to the therapeutic armamentarium. Today, we will discuss these drugs with expert...
Discussing β-lactamase/β-lactamase inhibitors (AAC Ed.)
Editors in Conversation - February 10, 2023 11:00 - 51 minutes ★★★★ - 10 ratingsNovel β-lactamase/β-lactamase inhibitors have become critical drugs to combat the most resistant Gram-negative infections. A series of new compounds with even more broad and potent activity are in the horizon to add to the therapeutic armamentarium. Today, we will discuss these drugs with expert...
Molecular Testing for Periprosthetic Joint Infections (JCM ed.)
Editors in Conversation - January 14, 2023 00:28 - 38 minutes ★★★★ - 10 ratingsThe applications of large multiplex panels for detection of pathogens have greatly expanded in the past several years. Initial tests were for detection of respiratory viruses, and the first such test was labor intensive and vulnerable to frequent contamination. Since then, additional sample type...
Exploring the book “Quit: The Power of Knowing When to Walk Away” by Annie Duke
IDEA Collider - December 28, 2022 13:35 - 1 hour ★★★★★ - 2 ratingsWelcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today, Annie Duke joins us on the show to discuss her latest book, “Quit: The Power of Knowing When to Walk Away.” Annie is an Author, Professional Speaker, Decision Strategist & co-founde...
Related Interviews Topics
- Comedy 777
- Music 590
- Business 548
- Interview 505
- News 478
- Culture 462
- Health 395
- Funny 387
- Science 339
- Women 276
- Entertainment 174
- Entrepreneurship 159
- Movies 157
- Politics 157
- Film 149
- Sports 128
- Books 122
- Art 121
- Stories 118
- Radio 110
- Marketing 100
- Inspiration 99
- Entrepreneur 98
- Music interviews 96
- Education 89
- Reviews 88
- Artists 83
- Arts 77
- Technology 76
- Authors 74
- Leadership 74
- Talk 70
- Relationships 70
- Musicians 69
- Comic 68
- Life 65
- History 64
- Lifestyle 63
- Celebrity 61
- Rock 60
- Conversations 58
- Entrepreneurs 58
- Writing 57
- Storytelling 57
- Celebrities 57
- Fitness 55
- Pop culture 55
- Television 55
- Actors 54
- Media 52